{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:55:28Z","timestamp":1788155728375,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05449-2","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T01:05:19Z","timestamp":1765933519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohammadreza","family":"Babaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Fallahtafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Rashedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ghaffari","family":"Jolfayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masih","family":"Tajdini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"36","key":"5449_CR1","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European society of cardiology (ESC), with the special contribution of the European heart rhythm association (EHRA) of the ESC. Endorsed by the European stroke organisation (ESO). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"11","key":"5449_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","volume":"20","author":"FHBM Schreuder","year":"2021","unstructured":"Schreuder FHBM, van Nieuwenhuizen KM, Hofmeijer J, Vermeer SE, Kerkhoff H, Zock E, et al. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial. Lancet Neurol. 2021;20(11):907\u201316.","journal-title":"Lancet Neurol"},{"issue":"10482","key":"5449_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","volume":"405","author":"R Veltkamp","year":"2025","unstructured":"Veltkamp R, Korompoki E, Harvey KH, Harvey ER, Fie\u00dfler C, Malzahn U, et al. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial. Lancet (London England). 2025;405(10482):927\u201336.","journal-title":"Lancet (London England)"},{"issue":"10","key":"5449_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","volume":"20","author":"R Al-Shahi Salman","year":"2021","unstructured":"Al-Shahi Salman R, Keerie C, Stephen J, Lewis S, Norrie J, Dennis MS, et al. Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial. Lancet Neurol. 2021;20(10):842\u201353.","journal-title":"Lancet Neurol"},{"issue":"6","key":"5449_CR5","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","volume":"48","author":"SB Murthy","year":"2017","unstructured":"Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, et al. Restarting anticoagulant therapy after intracranial hemorrhage: A systematic review and Meta-Analysis. Stroke. 2017;48(6):1594\u2013600.","journal-title":"Stroke"},{"issue":"3","key":"5449_CR6","first-page":"361","volume":"5","author":"YH Wu","year":"2025","unstructured":"Wu YH, Lin SY, Lin FJ, Tang SC, Wang CC. Outcomes of reinitiating direct oral anticoagulants after intracranial hemorrhage: A sequential target trial emulation study. JACC: Asia. 2025;5(3):361\u201370.","journal-title":"JACC: Asia"},{"issue":"12","key":"5449_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S1474-4422(23)00315-0","volume":"22","author":"R Al-Shahi Salman","year":"2023","unstructured":"Al-Shahi Salman R, Stephen J, Tierney JF, Lewis SC, Newby DE, Parry-Jones AR, et al. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurol. 2023;22(12):1140\u20139.","journal-title":"Lancet Neurol"},{"key":"5449_CR8","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"5449_CR9","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"7650","key":"5449_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"1","key":"5449_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"5449_CR12","doi-asserted-by":"publisher","first-page":"e1059","DOI":"10.1002\/hsr2.1059","volume":"6","author":"E Forfang","year":"2023","unstructured":"Forfang E, Larsen KT, Salman RA-S, Bell SM, Wester P, Berge E, et al. Antithrombotic treatment after intracerebral hemorrhage: surveys among stroke physicians in Scandinavia and the united Kingdom. Health Sci Rep. 2023;6(1):e1059.","journal-title":"Health Sci Rep"},{"issue":"6","key":"5449_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","volume":"70","author":"A Viswanathan","year":"2011","unstructured":"Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70(6):871\u201380.","journal-title":"Ann Neurol"},{"issue":"11","key":"5449_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jnnp-2016-314697","volume":"88","author":"G Banerjee","year":"2017","unstructured":"Banerjee G, Carare R, Cordonnier C, Greenberg SM, Schneider JA, Smith EE, et al. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry. 2017;88(11):982\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"5449_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"AP Carnicelli","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: Patient-Level network Meta-Analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022;145(4):242\u201355.","journal-title":"Circulation"},{"issue":"10","key":"5449_CR16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"7","key":"5449_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/WNL.0000000000004235","volume":"89","author":"E Korompoki","year":"2017","unstructured":"Korompoki E, Filippidis FT, Nielsen PB, Del Giudice A, Lip GYH, Kuramatsu JB, et al. Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. Neurology. 2017;89(7):687\u201396.","journal-title":"Neurology"},{"issue":"16","key":"5449_CR18","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.115.019794","volume":"133","author":"T-F Chao","year":"2016","unstructured":"Chao T-F, Liu C-J, Liao J-N, Wang K-L, Lin Y-J, Chang S-L, et al. Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage. Circulation. 2016;133(16):1540\u20137.","journal-title":"Circulation"},{"issue":"7","key":"5449_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/STROKEAHA.116.012945","volume":"47","author":"TP Ottosen","year":"2016","unstructured":"Ottosen TP, Grijota M, Hansen ML, Brandes A, Damgaard D, Husted SE, et al. Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage. Stroke. 2016;47(7):1837\u201343.","journal-title":"Stroke"},{"issue":"10482","key":"5449_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","volume":"405","author":"R Veltkamp","year":"2025","unstructured":"Veltkamp R, Korompoki E, Harvey KH, Harvey ER, Fie\u00dfler C, Malzahn U, et al. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2025;405(10482):927\u201336.","journal-title":"Lancet"},{"key":"5449_CR21","doi-asserted-by":"publisher","unstructured":"Kaisaier W, Guan C, Ye M, Guo S, Chen Y, Dong Y, Lip GYH, Liu C, Zhu W. Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage. Heart Rhythm. 2025;22(11):2836\u201344. https:\/\/doi.org\/10.1016\/j.hrthm.2025.06.023.","DOI":"10.1016\/j.hrthm.2025.06.023"},{"issue":"6","key":"5449_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","volume":"132","author":"PB Nielsen","year":"2015","unstructured":"Nielsen PB, Larsen TB, Skj\u00f8th F, Gorst-Rasmussen A, Rasmussen LH, Lip GY. Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent Stroke, Mortality, and bleeding: A nationwide cohort study. Circulation. 2015;132(6):517\u201325.","journal-title":"Circulation"},{"issue":"4","key":"5449_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/jamainternmed.2016.9369","volume":"177","author":"PB Nielsen","year":"2017","unstructured":"Nielsen PB, Larsen TB, Skj\u00f8th F, Lip GY. Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation. JAMA Intern Med. 2017;177(4):563\u201370.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"5449_CR24","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American heart association\/American stroke association. Stroke. 2022;53(7):e282\u2013361.","journal-title":"Stroke"},{"issue":"10411","key":"5449_CR25","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","volume":"402","author":"A Shoamanesh","year":"2023","unstructured":"Shoamanesh A. Anticoagulation in patients with cerebral amyloid angiopathy. Lancet. 2023;402(10411):1418\u20139.","journal-title":"Lancet"},{"key":"5449_CR26","doi-asserted-by":"publisher","unstructured":"Chen S, Chun KRJ, Ling Z, Liu S, Zhu L, Wang J, Schratter A, Acou WJ, Kiuchi MG, Yin Y, Schmidt B. Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update. J Cardiovasc Dev Dis. 2021;8(6):69. https:\/\/doi.org\/10.3390\/jcdd8060069.","DOI":"10.3390\/jcdd8060069"},{"issue":"13","key":"5449_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","volume":"392","author":"M Wazni Oussama","year":"2025","unstructured":"Wazni Oussama M, Saliba Walid I, Nair Devi G, Marijon E, Schmidt B, Hounshell T, et al. Left atrial appendage closure after ablation for atrial fibrillation. N Engl J Med. 2025;392(13):1277\u201387.","journal-title":"N Engl J Med"},{"issue":"4","key":"5449_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jacc.2025.04.069","volume":"86","author":"K-Y Chi","year":"2025","unstructured":"Chi K-Y, Chang Y, Lee P-L, Rossi R, Lin Y-S, Akman Z, et al. Anticoagulants for atrial fibrillation in survivors of intracranial hemorrhage. JACC. 2025;86(4):287\u201390.","journal-title":"JACC"},{"key":"5449_CR29","doi-asserted-by":"publisher","unstructured":"D'Anna L, Bax F, Abu-Rumeileh S, Barba L, Ornello R, Valente M, Gigli GL, Sacco S, Merlino G, Foschi M. Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry. 2025;96(10):919\u201327. https:\/\/doi.org\/10.1136\/jnnp-2025-336169.","DOI":"10.1136\/jnnp-2025-336169"},{"key":"5449_CR30","doi-asserted-by":"publisher","unstructured":"Kaisaier W, Guan C, Ye M, Guo S, Chen Y, Dong Y, Lip GYH, Liu C, Zhu W. Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage.\u00a0Heart Rhythm. 2025;22(11):2836\u201344.\u00a0https:\/\/doi.org\/10.1016\/j.hrthm.2025.06.023.\u00a0","DOI":"10.1016\/j.hrthm.2025.06.023"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05449-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05449-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05449-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:20:03Z","timestamp":1768994403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05449-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5449"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05449-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"57"}}